Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 2
2018 1
2019 1
2020 4
2021 5
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use.
Del Borgo C, Garattini S, Bortignon C, Carraro A, Di Trento D, Gasperin A, Grimaldi A, De Maria SG, Corazza S, Tieghi T, Belvisi V, Kertusha B, De Masi M, D'Onofrio O, Bagaglini G, Bonanni G, Zuccalà P, Fabietti P, Tortellini E, Guardiani M, Spagnoli A, Marocco R, Alunni Fegatelli D, Lichtner M, Latina Covid-Group. Del Borgo C, et al. Among authors: zuccala p. Viruses. 2023 Apr 21;15(4):1025. doi: 10.3390/v15041025. Viruses. 2023. PMID: 37113006 Free PMC article.
Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves.
Marocco R, Del Borgo C, Tortellini E, Garattini S, Carraro A, Di Trento D, Gasperin A, Grimaldi A, Tieghi T, Belvisi V, Kertusha B, Guardiani M, Zuccalà P, Alunni Fegatelli D, Spagnoli A, Lichtner M, Latina Covid-Group. Marocco R, et al. Among authors: zuccala p. Viruses. 2023 Apr 11;15(4):947. doi: 10.3390/v15040947. Viruses. 2023. PMID: 37112927 Free PMC article.
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH.
Tortellini E, Zingaropoli MA, Mancarella G, Marocco R, Carraro A, Jamhour M, Barbato C, Guardiani M, Dominelli F, Pasculli P, Napoli A, Gaeta A, Mengoni F, Zuccalà P, Belvisi V, Kertusha B, Parente A, Del Borgo C, Vullo V, Ciardi MR, Mastroianni CM, Lichtner M, Latina Covid-Group. Tortellini E, et al. Among authors: zuccala p. Int J Mol Sci. 2022 Nov 30;23(23):14988. doi: 10.3390/ijms232314988. Int J Mol Sci. 2022. PMID: 36499317 Free PMC article.
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects.
Zuccalà P, Latronico T, Marocco R, Savinelli S, Vita S, Mengoni F, Tieghi T, Borgo C, Kertusha B, Carraro A, D'Ettorre G, Vullo V, Mastroianni CM, Liuzzi GM, Lichtner M. Zuccalà P, et al. Int J Mol Sci. 2022 Oct 8;23(19):11936. doi: 10.3390/ijms231911936. Int J Mol Sci. 2022. PMID: 36233234 Free PMC article.
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients.
Marocco R, Carraro A, Zingaropoli MA, Nijhawan P, Tortellini E, Guardiani M, Mengoni F, Zuccalà P, Belvisi V, Kertusha B, Parente A, Del Borgo C, Vullo V, Ciardi MR, Mastroianni CM, Lichtner M. Marocco R, et al. Among authors: zuccala p. Front Immunol. 2022 Apr 4;13:871592. doi: 10.3389/fimmu.2022.871592. eCollection 2022. Front Immunol. 2022. PMID: 35444637 Free PMC article.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study.
Russo G, Solimini A, Zuccalà P, Zingaropoli MA, Carraro A, Pasculli P, Perri V, Marocco R, Kertusha B, Del Borgo C, Del Giudice E, Fondaco L, Tieghi T, D'Agostino C, Oliva A, Vullo V, Ciardi MR, Mastroianni CM, Lichtner M. Russo G, et al. Among authors: zuccala p. PLoS One. 2021 Sep 10;16(9):e0257376. doi: 10.1371/journal.pone.0257376. eCollection 2021. PLoS One. 2021. PMID: 34506608 Free PMC article.
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M. Zingaropoli MA, et al. Among authors: zuccala p. Front Immunol. 2021 Feb 26;12:627548. doi: 10.3389/fimmu.2021.627548. eCollection 2021. Front Immunol. 2021. PMID: 33777012 Free PMC article.
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection.
Mussini C, Cozzi-Lepri A, Menozzi M, Meschiari M, Franceschini E, Milic J, Brugioni L, Pietrangelo A, Girardis M, Cossarizza A, Tonelli R, Clini E, Massari M, Bartoletti M, Ferrari A, Cattelan AM, Zuccalà P, Lichtner M, Rossotti R, Girardi E, Nicastri E, Puoti M, Antinori A, Viale P, Guaraldi G. Mussini C, et al. Among authors: zuccala p. PLoS One. 2021 Feb 23;16(2):e0247275. doi: 10.1371/journal.pone.0247275. eCollection 2021. PLoS One. 2021. PMID: 33621264 Free PMC article.
19 results